Resistance to β-lactam antibiotics

K Poole - Cellular and Molecular Life Sciences CMLS, 2004 - Springer
Abstract β-lactams have a long history in the treatment of infectious diseases, though their
use has been and continues to be confounded by the development of resistance in target …

Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey

H Arslan, ÖK Azap, Ö Ergönül… - Journal of Antimicrobial …, 2005 - academic.oup.com
Objectives: To determine the risk factors for community-acquired ciprofloxacin-resistant
Escherichia coli urinary tract infection (UTI). Methods: The study was performed with isolates …

Dramatic Increase in Prevalence of Fecal Carriage of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae during Nonoutbreak Situations in Spain

A Valverde, TM Coque… - Journal of clinical …, 2004 - Am Soc Microbiol
The occurrence of extended-spectrum β-lactamase (ESBL)-producing isolates has
increased worldwide. Fecal carriage of ESBL-producing isolates has mainly been detected …

Evolution and Epidemiology of Multidrug-Resistant Klebsiella pneumoniae in the United Kingdom and Ireland

D Moradigaravand, V Martin, SJ Peacock, J Parkhill - MBio, 2017 - Am Soc Microbiol
Klebsiella pneumoniae is a human commensal and opportunistic pathogen that has become
a leading causative agent of hospital-based infections over the past few decades. The …

Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection

WE Van der Starre, C Van Nieuwkoop… - Journal of …, 2011 - academic.oup.com
Objectives To assess risk factors for fluoroquinolone resistance in community-onset febrile
Escherichia coli urinary tract infection (UTI). Methods A nested case–control study within a …

High prevalence of Mucosa-Associated extended-spectrum β-Lactamase-producing Escherichia coli and Klebsiella pneumoniae among Iranain patients with …

AA Kharaghani, N Harzandi, B Khorsand… - Annals of Clinical …, 2023 - Springer
Background Several pieces of evidence suggest that certain pathobionts belonging to
Enterobacterales are associated with the development and progression of inflammatory …

Prevalence and antimicrobial susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital

AA Kader, A Kumar - Annals of Saudi medicine, 2005 - annsaudimed.net
BACKGROUND: The prevalence of extended-spectrum β-lactamases (ESBLs) varies
between countries and institutions. We studied the prevalence of ESBL among clinical …

[HTML][HTML] Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases

L Romero, L Lopez, J Rodriguez-Bano… - Clinical microbiology …, 2005 - Elsevier
ABSTRACT In total, 438 (1.7%) Escherichia coli and 125 (3.98%) Klebsiella pneumoniae
isolates were found to be producers of extended-spectrum β-lactamase (ESBL) during 1995 …

High burden of intestinal colonization with antimicrobial-resistant bacteria in Chile: an antibiotic resistance in communities and hospitals (ARCH) study

R Araos, RM Smith, A Styczynski… - Clinical Infectious …, 2023 - academic.oup.com
Background Antimicrobial resistance is a global threat, heavily impacting low-and middle-
income countries. This study estimated antimicrobial-resistant gram-negative bacteria (GNB) …

[HTML][HTML] Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum β …

L López-Cerero, E Picón, C Morillo… - Clinical Microbiology …, 2010 - Elsevier
A significant inoculum-size effect has been observed with piperacillin-tazobactam, and has
been associated with β-lactamase production in extended-spectrum β-lactamase (ESBL) …